Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.45 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dipentylamine SCHEMBL28374593 | 0.92 | ALDH1A1 (0.68) | TSHRALDH1A1PAOXEPHX1ADH1B | |
| Bicarbonate SCHEMBL28699185 | 0.92 | TSHR (0.58) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Bicarbonate SCHEMBL910039 | 0.92 | TSHR (0.58) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetone SCHEMBL2671636 | 0.92 | TSHR (0.58) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetic Acid SCHEMBL10959642 | 0.91 | ALOX15 (0.50) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetic Acid SCHEMBL5027801 | 0.91 | PAOX (0.47) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetic Acid SCHEMBL17222430 | 0.91 | PAOX (0.47) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetic Acid SCHEMBL5571306 | 0.90 | TSHR (0.70) | TSHRALDH1A1PAOXALOX15EPHX1 | |
| Acetic Acid SCHEMBL6397604 | 0.90 | ALDH1A1 (0.65) | TSHRALDH1A1PAOXEPHX1ADH1B | |
| Acetic Acid SCHEMBL6396718 | 0.90 | ALDH1A1 (0.65) | TSHRALDH1A1PAOXEPHX1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665306-A1 | ANALYTICAL METHOD | GlaxoSmithKline Biologicals S.A. (BE) | 2025-12-24 | — | — | EP | claimed |
| US-20250362278-A1 | MASS SPECTROMETRY OF MRNA | MODERNATX, INC. (US) | 2025-11-27 | — | — | US | claimed |
| EP-4638783-A2 | METHODS FOR ANALYZING NUCLEIC ACID CARGOS OF LIPID NUCLEIC ACID ASSEMBLIES | Intellia Therapeutics, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4565694-A1 | EXTRACTION-LESS REVERSE PHASE (RP) CHROMATOGRAPHY FOR MRNA PURITY ASSESSMENT | ModernaTX, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| CN-116554015-B | Method for preparing methacrolein through Mannich reaction | 中国科学院过程工程研究所 | 2025-04-25 | — | — | CN | claimed |
| CN-119757584-A | Method for detecting RNA-LNP samples | 上海药明生物技术有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-20250092440-A1 | EXTRACTION-LESS REVERSE PHASE (RP) CHROMATOGRAPHY OF MRNA ENCAPSULATED IN LIPID NANOPARTICLES FOR MRNA PURITY ASSESSMENT | MODERNATX, INC. (US) | 2025-03-20 | — | — | US | claimed |
| EP-4426853-A1 | MASS SPECTROMETRY OF MRNA | ModernaTX, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| WO-2024171052-A1 | ANALYTICAL METHOD | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-08-22 | — | — | WO | claimed |
| WO-2024138189-A2 | METHODS FOR ANALYZING NUCLEIC ACID CARGOS OF LIPID NUCLEIC ACID ASSEMBLIES | INTELLIA THERAPEUTICS, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| EP-3359680-B1 | METHODS FOR DETECTING OR QUANTIFYING CTP AND CTP SYNTHASE ACTIVITY | HOPITAUX PARIS ASSIST PUBLIQUE (FR) | 2020-10-07 | — | — | EP | claimed |
| CN-111575336-A | Method for acquiring metabolic flux of intracellular central carbon metabolic pathway under metabolic steady isotope unsteady state | 华东理工大学 | 2020-08-25 | — | — | CN | claimed |
| US-10731197-B2 | Methods for detecting or quantifying CTP and CTP synthase activity | ASSITANCE PUBLIQUE-HOPITAUX DE PARIS (FR) | 2020-08-04 | — | — | US | claimed |
| US-20200239869-A1 | ANALYTICAL HPLC METHODS | MODERNATX, INC. (US) | 2020-07-30 | — | — | US | claimed |
| EP-3668977-A1 | ANALYTICAL HPLC METHODS | Modernatx, Inc. (US) | 2020-06-24 | — | — | EP | claimed |
| WO-2019036683-A1 | ANALYTICAL HPLC METHODS | MODERNATX, INC. (US) | 2019-02-21 | — | — | WO | claimed |
| US-20180298420-A1 | Methods For Detecting Or Quantifying CTP And CTP Synthase Activity | ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (FR) | 2018-10-18 | — | — | US | claimed |
| WO-2017060534-A1 | METHODS FOR DETECTING OR QUANTIFYING CTP AND CTP SYNTHASE ACTIVITY | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) | 2017-04-13 | — | — | WO | claimed |
| CN-104558612-A | Alkoxy-terminated polysiloxane polymer and preparation method thereof | ZHEJIANG WYNCA CHEMICAL INDUSTRY GROUP CO LTD | 2015-04-29 | — | — | CN | claimed |
| US-6028231-A | Process for preparing 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-02-22 | — | — | US | claimed |